Literature DB >> 8733768

Expression of Pit-1 and estrogen receptor messenger RNA in prolactin-producing pituitary adenomas.

N Sanno1, A Teramoto, A Matsuno, S Takekoshi, J Itoh, R Y Osamura.   

Abstract

The pituitary-specific transcriptional factor, Pit-1, is a member of the POU-domain family, which has a role in the development and differentiation of three pituitary cell types: somatotrophs, lactotrophs, and thyrotrophs. Recently, specific DNA-dependent interactions have been observed between Pit-1 and nuclear receptors, including: thyroid hormone receptor; retinoic acid receptor; glucocorticoid receptor; and estrogen receptor (ER). The cooperative interaction between Pit-1 and ER required for prolactin enhancer activity in rat pituitaries has been suggested. We analyzed the expression of Pit-1 messenger ribonucleic acid (mRNA) and ER mRNA in 15 human prolactin-producing adenomas using nonradioisotopic in situ hybridization. Their products were also studied by immunohistochemical analysis. Pit-1 mRNA was detected in 12 (80%) of 15 prolactin-producing adenomas. On the other hand, ER mRNA was detected in 14 (94%) of adenomas studied. mRNAs of Pit-1 and ER were detected more frequently than immunohistochemical expression of their products. By combined in situ hybridization and immunohistochemical examination, Pit-1 mRNA and ER mRNA were often colocalized with prolactin immunoreactivities. The colocalizations of Pit-1 mRNA and ER protein were observed in adenoma cells. The high incidence of the expression of ER mRNA in prolactin-producing adenomas may suggest cooperative interactions between Pit-1 and ER in functional differentiation and development of prolactin-producing adenomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8733768

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

Review 1.  Pit-1 positive alpha-subunit positive nonfunctioning human pituitary adenomas: a dedifferentiated GH cell lineage?

Authors:  R Y Osamura; S Tahara; K Komatsubara; Y Itoh; H Kajiwara; R Kurotani; N Sanno; A Teramoto
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

2.  Expression of Ptx1 in the adult rat pituitary glands and pituitary cell lines: hormone-secreting cells and folliculo-stellate cells.

Authors:  R Kurotani; S Tahara; N Sanno; A Teramoto; P L Mellon; K Inoue; S Yoshimura; R Y Osamura
Journal:  Cell Tissue Res       Date:  1999-10       Impact factor: 5.249

3.  Reverse transcription polymerase chain reaction analysis of pituitary hormone, Pit-1 and steroidogenic factor-1 messenger RNA expression in pituitary tumors.

Authors:  M T McDermott; B R Haugen; D F Gordon; W M Wood; N S Brown; C A Bauer; M J Garrity; B K Kleinschmidt-DeMasters; K O Lillehei; M H Samuels; T M Bright; E C Ridgway
Journal:  Pituitary       Date:  1999-11       Impact factor: 4.107

Review 4.  Recent progress in studies of pituitary tumor pathogenesis.

Authors:  Takeo Minematsu; Shunsuke Miyai; Hanako Kajiya; Masanori Suzuki; Naoko Sanno; Susumu Takekoshi; Akira Teramoto; Robert Y Osamura
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

5.  Pituitary Sex Steroid Receptors: Localization and Function.

Authors:  Lucia Stefaneanu
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

6.  Molecular Pathology of the Pituitary Adenomas.

Authors:  Naoko Sanno; Robert Y. Osamura
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

7.  Expression of MSX1 in human normal pituitaries and pituitary adenomas.

Authors:  Yoshihito Mizokami; Noboru Egashira; Susumu Takekoshi; Johbu Itoh; Yoshiko Itoh; Robert Yoshiyuki Osamura; Mitsunori Matsumae
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

8.  Pituitary changes in Prop1 transgenic mice: hormone producing tumors and signet-ring type gonadotropes.

Authors:  Noboru Egashira; Takeo Minematsu; Syunsuke Miyai; Susumu Takekoshi; Sally A Camper; Robert Y Osamura
Journal:  Acta Histochem Cytochem       Date:  2008-06-27       Impact factor: 1.938

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.